Sigma binding site agents having the formula ##STR1## which are useful to inhibit sigma binding site-induced activity, pharmaceutical compositions including these agents, and methods of using these agents to inhibit sigma binding site-induced activity in mammals. Also disclosed are novel intermediates useful in preparing the presently invented agents.
具有以下
化学式的Sigma结合位点
抑制剂,可用于抑制Sigma结合位点诱导的活性,包括这些剂的药物组合物,以及使用这些剂在哺乳动物中抑制Sigma结合位点诱导的活性的方法。还公开了在制备目前发明的剂中有用的新型中间体。